DIN 02437341 — ICLUSIG 45 MG
ICLUSIG is a tablet of Ponatinib marketed by TAKEDA PHARMACEUTICALS U.S.A., INC.. The full Ponatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02437341
- Brand name
- ICLUSIG
- Active ingredient
- Ponatinib
- Strength
- 45 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TAKEDA PHARMACEUTICALS U.S.A., INC.
- Health Canada status
- DORMANT
- Drug class
- Protein-tyrosine kinase inhibitor (BCR-ABL inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ponatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02437333 | ICLUSIG | 15 MG | TABLET | TAKEDA PHARMACEUTICALS U.S.A., INC. | MARKETED |